A University of Toronto professor's research on the physiology of sleep and breathing has paved the way for a new sleep apnea treatment that recently ...

You snore because your airway was redesigned for language. That structural trade-off has been with us for 40,000 years.

Dr. Jaclyn Smeaton, ND   A clinical review of the landmark renaming of PCOS to PMOS and why this shift reframes the condition ...

A large phase 3 clinical trial has revealed promising results for a once-nightly pill designed to treat obstructive sleep ...

AD109 works by targeting neuromuscular dysfunction of upper airway muscles during sleep, representing a potential new ...

A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ATS International Conference. The drug, called AD109, is the first therapy to ...

A University of Toronto professor’s research on the physiology of sleep and breathing has paved the way for a new sleep apnea treatment that recently reported positive results in a phase 3 clinical ...

A new treatment breakthrough at University of Utah Health is bringing relief to children with Down syndrome and sleep apnea. Families are finding new hope as kids breathe—and sleep—more easily.

THERE’S BEEN A lot of talk of “revolutionary” drugs lately, thanks to GLP-1s like Ozempic that changed how obesity is treated. Now scientists are trying to replicate a similar groundbreaking feat in ...

Nearly 70% of patients with positional obstructive sleep apnea who discontinued positional therapy after achieving disease ...

Among adults with mild to severe obstructive sleep apnea, those receiving AD109, an oral combination drug, vs. placebo ...

New research shows Ozempic may reduce sleep apnea severity by over 50%. Here's what the science actually says.